Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats

Journal of Hepatology

Volumn 32, Issue 3, 2000, Pages 434-440

  Veal, Nary ^b   Oberti, Frédéric ^b   Moal, Frédéric ^b   Vuillemin, Eric ^b   Fort, Joël ^b   Kaassis, Mehdi ^b   Pilette, Christophe ^b   Calès, Paul ^a  

^a Serv d'Hepato Gastroenterol   (France)

^b NONE

Author keywords

Hemodynamics; Liver fibrosis; Octreotide; Portal hypertension; Splenorenal shunt blood flow; Transit time ultrasound

Indexed keywords

CARBON TETRACHLORIDE; MICROSPHERE; OCTREOTIDE; VAPREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; ECHOGRAPHY; HEMODYNAMICS; MESENTERIC VEIN; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SPLENIC VEIN; SPLENORENAL SHUNT; VEIN LIGATION;

EID: 0034009735     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80394-3     Document Type: Article

References (23)

1. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Terès J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 346:1995;1056-1059.
2. Nevens F, Bustami R, Scheys I, Lesaffre E, Fevery J. Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. Hepatology. 27:1998;15-19.
3. Escorcell A, Castaneda B, Bordas JM, Debernardi-Venon W, Feu F, Ginès A, et al. Predictive value of the variceal pressure response to continued pharmacological therapy for portal hypertension in patients with cirrhosis. [abstract] Hepatology. 28:1998;771A.
4. Calès P, Braillon A, Jiron MI, Lebrec D. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis, lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol. J Hepatol. 1:1984;37-46.
5. McCormick P, Greenslade L, Chin J, Dick R, McIntyre N, Burroughs A. The effect of the combination of octreotide and metoclopramide on azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol. 10:1993;839-843.
6. Calès P, Oberti F, Veal N, Fort J, Kaassis M, Moal F, Aubé C, et al. Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats. Hepatology. 28:1998;1269-1274.
7. Mosca P, Lee FY, Kaumann AJ, Groszmann RJ. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol. 263:1992;G544-G550.
8. Halvorsen JF, Myking AO. The porto-systemic collateral pattern in the rat. Eur Surg Res. 6:1974;183-195.
9. Lebrec D. Animals models of portal hypertension. Okuda K, Benhamou JP. Portal Hypertension: Clinical and Physiological Aspects. 1991;101-113 Springer-Verlag, Tokyo.
10. Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology. 83:1982;1183-1190.
11. Oberti F, Pilette C, Rifflet H, Maiga M, Moreau A, Gallois Y, et al. Effects of simvastatin, pentoxyfylline and spironolactone on hepatic fibrosis and portal hypertension in cirrhotic rats. J Hepatol. 26:1997;1363-1371.
12. Calès P, Braillon A, Girod C, Lebrec D. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats. J Hepatol. 1:1985;349-357.
13. Moal F, Oberti F, Pilette C, Veal N, Kaassis M, Fort J, et al. Chronic hemodynamic and antifibrotic effects of vapreotide in cirrhotic rats. [abstract] Hepatology. 28:1998;559A.
14. Ishise S, Pegram BL, Yamamoto J, Kitamura Y, Frohlich ED. Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol. 239:1980;H443-H449.
15. Geraghty JG, Angerson WJ, Carter DC. Portal venous pressure and portosystemic shunting in experimental portal hypertension. Am J Physiol. 257:1989;G52-G57.
16. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the the rat using γ-labeled microspheres. Am J Physiol. 240:1981;G371-G375.
17. Snedecor GW, Cochran WG. Statistical Methods, 8th ed. 1989;Iowa State University Press, Ames (Iowa).
18. Groszmann RJ, Vorobioff J, Riley E. Splanchnic hemodynamics in portal-hypertensive rats: measurement with γ-labeled microspheres. Am J Physiol. 242:1982;G156-G160.
19. Lin HC, Yang MC, Hou MC, Li SM, Huang YT, Yu PC, et al. Effects of long term administration of octreotide in portal vein stenosed rats. Hepatology. 23:1996;537-543.
20. Bono RF, Moreno AH, Rousselot LM, Panke WF. Studies on portal hypertension. V. A comparison between the experimentally induced state of portal hypertension and that observed in human beings. Surgery. 48:1960;119-141.
21. 4-treated cirrhotic rats. Clin Sci. 93:1997;549-556.
22. D'Almeida MS, Cailmail S, Lebrec D. Validation of transit-time ultrasonic flow probes to directly measure portal blood flow in conscious rats. Am J Physiol. 271:1996;H2701-H2709.
23. Rodriguez-Pérez F, Groszmann RJ. Pharmacologic treatment of portal hypertension. Gastroenterol Clin N Amer. 21:1992;15-40.